Thursday 13 December 2018
Home      All news      Contact us      India
business-standard - 1 month ago

Aurobindo inks pact to acquire Australian pharma firm s

Aurobindo Pharma has said it s wholly-owned subsidiaryhas entered into an agreement to acquire a product under development and related assets from Australia-based Advent Pharmaceuticals Pty Ltd for USD 12.5 million. Our wholly-owned subsidiary, Aurobindo Pharma USA Inc., USA, has entered into an agreement to acquire a product under development and related assets from Advent Pharmaceuticals Pty Ltd, Australia, through AuroScience Pty Limited, Melbourne, a 100 per cent subsidiary of Aurobindo Pharma USA Inc, USA, a regulatory filing from Aurobindo said Monday. Based out of Melbourne, Advent Pharmaceuticals is engaged in developing and commercialising generic inhaled medicines for global markets.

Related news

Latest News
Hashtags:   

Aurobindo

 | 

acquire

 | 

Australian

 | 

pharma

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources